Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -28.85x is 161% below its 1-year average of -11.06x, near the low end of its 1-year range (-28.85x–-10.45x).
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-28.85x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-352.55%
vs the sector median at left
Zenas BioPharma, Inc.
Market Cap
$1.70B
Interest Coverage Ratio
-28.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Interest Coverage Ratio
2.86x
TTM Avg
2.86x
3Y Avg
2.86x
5Y Avg
6.42x
Market Cap
$1.71B
Interest Coverage Ratio
-429.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.73B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.74B
Interest Coverage Ratio
0.93x
TTM Avg
0.93x
3Y Avg
0.93x
5Y Avg
0.93x
Market Cap
$1.74B
Interest Coverage Ratio
0.86x
TTM Avg
0.86x
3Y Avg
0.86x
5Y Avg
0.86x
Market Cap
$1.74B
Interest Coverage Ratio
-596.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.75B
Interest Coverage Ratio
1.43x
TTM Avg
1.58x
3Y Avg
1.58x
5Y Avg
1.43x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zenas BioPharma, Inc. (ZBIO) | $1.70B | -28.85x | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 2.86x | 2.86x | 2.86x | 6.42x |
| Personalis, Inc. (PSNL)vs › | $1.71B | -429.55x | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | N/A | N/A | N/A | N/A |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 0.93x | 0.93x | 0.93x | 0.93x |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | 0.86x | 0.86x | 0.86x | 0.86x |
| Absci Corporation (ABSI)vs › | $1.74B | -596.74x | N/A | N/A | N/A |
| Novocure Ltd (NVCR)vs › | $1.74B | N/A | 1.68x | 1.68x | 1.68x |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 1.43x | 1.58x | 1.58x | 1.43x |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | -206.92x | N/A | N/A | N/A |
Interest Coverage
-28.9x
Debt/Equity
1.58
Current Ratio
9.93
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -10.45x |
| 2026-03-31 | -11.66x |
